Cerus in the News

November 3, 2018
Hematology Times - Breakthrough designation for pathogen-reduced cryoprecipitate  

November 21, 2016
East Bay Economic Development Alliance - Cerus Selected as an East Bay Innovation Awards Finalist for Life Sciences 


September 12, 2016
San Francisco Business Times - How this East Bay company is helping squash Zika


September 5, 2016
Chemical & Engineering News -  Zika is boon to device makers; Blood tests and purification methods ramp up as FDA recommends U.S.-wide screening

August 26, 2016
Wired - Testing for Zika Isn't the Only Way to Keep the Blood Supply Safe


July 28, 2016
Reuters - FDA takes steps to protect blood supply in Florida amid Zika probe


July 20, 2016
NBC Bay Area -  Concord Biotech Company Cerus Donates Blood Sterilization Tech to Rio Ahead of Olympic Games


July 19, 2016
Fox Illinois - Zika Virus Safety Concerns for the Blood Supply

July 19, 2016
ABC Channel 7 News San Francisco -  Blood Donation Centers Make Plea for Donors Among Nationwide Shortage

July 14, 2016
San Francisco Chronicle - Concord's Cerus Helps Ensure Blood Safety for Rio Olympics 


June 20, 2016
FierceMedical Devices - Cerus snags up to $180M from BARDA for blood pathogen reduction system


February 11, 2016
Wired – The U.S. Has the Tech to Keep Zika Out of the Blood Supply


September 28, 2015
The Wall Street Journal - The Rising Risk of a Contaminated Blood Supply; Amid new pathogens and cost pressures, efforts are under way to keep patients safe


June 16, 2015
Scientific American – The INTERCEPT Blood System Rids Blood Donations of All Pathogens


June 11, 2015
Science News for Students – A Germ Stopper for Blood Products

May 29, 2015
Transfusion News – Implementation of Pathogen Reduction in the United States (VIDEO)

March 24, 2015
FORBES – A Bug Zapper for Blood: Intercept System Deactivates Pathogens in Donated Plasma

January 26, 2015
Med Device Online CEO Corner: Interview with Obi Greenman, President & CEO of Cerus –
Development of a Pathogen Inactivation System to Stop Ebola and Other Deadly Outbreaks

December 17, 2014
Hematology Times – FDA Approves Pathogen Inactivation System for Plasma


Any links to third party Web pages from this Web site are provided for your convenience only. Cerus does not monitor, author, edit, or endorse any information provided in these third party pages and assumes no responsibility for the accuracy of their content.

  • Global Headquarters

  • 2550 Stanwell Drive
    Concord, CA US 94520
    +1 925.288.6000
  • European Headquarters

  • Stationsstraat 79-D
    3811 MH Amersfoort, Netherlands
    +31 (0) 33 49 60 600